Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global wound care market was valued at USD 22.05 billion in 2023, driven by the increasing prevalence of chronic wounds across the globe. The market size is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 34.21 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advanced wound care products are intended to heal and treat complicated injuries such as venous ulcers, foot ulcers, along with stress ulcers. The increasing incidence of hard-to-heal injuries and increasing acceptance of the product in the healthcare sector are driving the growth of the industry. The developments and innovations in the industry, coupled with growing prevalence of diabetes, rapid growth in the geriatric population, and increasing funding for research are the driving factors which are accelerating the growth of wound care industry. Moreover, an increasing number of road accidents and trauma injuries globally, and growing awareness programs for wound care treatment and management across impact the market growth positively. The high cost of advanced products and risks associated with the products are the drawbacks that may affect the wound care market growth in the forecast period.
Strategic Collaborations Between Market Players Propelling Market Growth
In March 2023, Bactiguard, a global MedTech company specialising in the development of biocompatible technologies that prevent medical device-related infections launched its wound care range in the UK and Ireland, in collaboration with Quintess Medical and GS Medical. Healing of a wound becomes challenging when bacteria along with other microorganisms develop in the wound. Wound dressings play a vital role in avoiding the discomfort caused by the bacteria. When compared to traditional wound management market, there is a shift towards biocompatible and pH-neutral products which support an improved wound healing process. They also clean the wound by reducing the microbial load. The Bactiguard product line can be used for both acute and chronic wounds as it is categorised as a non-toxic and environmentally friendly class III medical device.
The market is expected to be propelled by such collaborations as they expand the cross-regional market presence of healthcare’s leading players and make the company offerings available in other regions as well. This collaboration is poised to further strengthen Bactiguard’s position in the advanced wound care market, bolstering the market growth.
Escalating Financial Support Bolstering Market Growth
The market is receiving significant financial support boosting the development of novel products in the market. It is witnessing escalating demand for advanced wound care in every domain including military settings. For instance, in January 2024, 3M Health Care's Medical Solutions Division, the world leader in advanced wound care, received financial support of USD 34.2 million from the U.S. Army Medical Research Acquisition Activity. The fund has been offered to the company to develop a range of new solutions for infection prevention, wound management, and wound healing.
The wound dressing market is anticipated to be influenced positively by such strategic investments. The financial support will enable research activities for the development of novel solutions in advanced wound care leading to the availability of enhanced solutions. 3M will work on a program focused on strategies of treatment that can be used in critical settings. The program will work to assess biofilm control, biomarker monitoring, and healing in acute trauma situations such as blasts, burns, and gunshot wounds that occur in civilian and military settings. It will also work for both civilians and military settings and enable wide applications. The development of such novel solutions may also increase wound dressing market demand and strengthen the company’s market position.
Continuous Comprehension and Co-operation from Regulatory Authorities
The increasing demand for advanced wound care products in the market has resulted in a comprehension of the situation by the regulatory authorities. With increasing chronic injuries globally, the need to develop advanced wound care products and devices is necessary. With continuous efforts by market players, regulatory authorities like the US FDA (United States Food and Drug Administration) also play a crucial role in market growth. In April 2024, PowerHeal™, a bioelectric bandage that was approved by the Food and Drug Administration (FDA) for over the counter (OTC) use for wound management, was made available by Vomaris.
It is indicated for superficial wounds such as minor cuts, scrapes, irritations, abrasions, and blisters and is available in a variety of sizes. It minimizes the risk of infection and is FDA approved backed by the notable results from RCTs which adds to the credibility of the product. All these factors are likely to augment the advanced wound therapy devices market share in the forecast period. The FDA approval was based on multiple clinical trials demonstrating the efficacy of the bioelectric bandage, comparing the wireless electroceutical dressing (WED) to the standard of care treatment (such as debridement, negative pressure wound therapy, skin grafting) in 38 patients with burn wounds.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Research and Development Activities
The market is witnessing increasing research and development activities by researchers to develop new products and wound dressing effective enough to provide enhanced patient outcomes, propelling market demand.
Product Development
Several market players are putting continuous efforts toward innovating wound care for healthcare professionals and patients. The market is witnessing a rising trend toward the development of personalized wound care and multiple product launches in the market.
Increasing FDA Approvals
The wound care industry statistics reveal that several innovative wound care dressings and devices are being developed by major market players. Hence, regulatory bodies like United States FDA are providing approvals to bring latest and efficient treatment alternatives to patients. It is also triggering market competition and providing opportunities to other market players as well.
Recent Developments in the Market
In April 2024, a world leading MedTech company specialised in wound care and wound management, Mölnlycke Health Care, announced the acquisition of P.G.F. Industry Solutions GmbH, the Austrian manufacturer of Granudacyn wound cleansing and moisturizing solutions. Mölnlycke and P.G.F. have worked together for five years on the manufacturing and distribution of Granudacyn, a range of solution and gel products intended for use in the cleansing, irrigation, and moisturisation of various wound types. The high quality and composition of Granudacyn ensures good biocompatibility, allowing it to be effectively used on a broad range of tissues in burns, as well as acute and chronic wounds.
This strategic acquisition of P.G.F by Mölnlycke Health Care is dedicated to facilitating different types of wound care management. Following the acquisition, Mölnlycke Health Care will gain access to the outstanding product portfolio of P.G.F and trigger competition among other market players in the market. When the expertise and resources of both companies are integrated, it may likely lead to the enhanced innovation and development of new wound care products in the market expanding the market size.
In April 2023, the innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, was approved by the Food and Drug Administration (FDA) for hydromechanical removal of infectious materials, non-viable tissue and wound debris. This reduces the need for surgical debridement while promoting the formation of granulation tissue, creating an environment that supports wound healing. The FDA approval adds credibility to the therapy and plays a crucial role in making it available to healthcare providers and patients, thereby impacting the market positively.
Market Breakup by Product Type
Market Breakup by Wound Type
Market Breakup by Mode of Purchase
Market Breakup by End User
Market Breakup by Region
Market Segmentation by Product Type Poised to Experience Substantial Growth
Based on product type segmentation, the global wound care market is broadly segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound care devices. Advanced wound care includes personalized treatments for chronic wounds or the ones that couldn’t heal through traditional wound care. With increasing efforts of researchers and pharmaceutical companies to develop advanced wound dressings including foam dressing, hydrocolloid dressing, and hydrogel dressings, among other advanced dressings, the wound dressing market is expected to witness an upward trajectory in the forecast period. Advanced wound care dressings are also poised to rapidly grow due to the increasing demand for advanced and effective wound care suitable for both homecare and hospital settings.
Chronic Wounds are Likely to Account for a Significant Market Share Based on Wound Types
Based on the wound care market analysis, the segmentation based on wound types is divided into chronic and acute wounds. Chronic wounds such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others are expected to account for a notable market value. The rising prevalence of chronic diseases such as diabetes and conditions associated with it like foot ulcers and venous ulcers among others are contributing to the increased demand for specialized wound care to provide effective healing process and enhance patient outcomes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on regions, the market includes North America, Europe, Asia-Pacific, Latin America, along with Middle East and Africa. The market is dominated by North America due to the increasing prevalence of chronic injuries. The wound care market in U.S. is poised to experience increasing injuries led by rising prevalence of accidents and chronic diseases in the region. The market is further driven by the growing geriatric population. Moreover, the presence of several market players also contributes to the market value.
The wound care market in the UK is anticipated to be driven by the increasing development of new wound care dressings and devices. Apart from general wound care companies, the United Kingdom has around 66 advanced wound-care companies. Hence, the market value for advanced wound care is projected to bring several technically advanced wound care dressings and devices in the market. Moreover, fundings and investments from vital government bodies like National Health Service (NHS) is also impacting the market positively.
The Asia Pacific region, countries like China, Japan, and India account for a notable market share. The wound care market in India is growing, driven by the presence of a large patient pool and investments in medical research and infrastructure to provide effective wound management. The country is experiencing an increasing prevalence of diabetes leading to chronic wounds such as diabetic foot ulcers, which is demanding for effective and advanced wound care management devices. The rising number of road accidents are also contributing to the market growth.
The Middle East and Africa wound care market is experiencing growth due to rising healthcare investments and increasing awareness about wound care management. Countries in this region are adopting advanced wound care technologies to improve patient care.
The key features of the market report include patent analysis, and strategic initiatives which includes recent partnerships, collaborations and acquisitions by the leading players. The major companies in the market are as follows:
3M Company
The company was founded in 1902 and is headquartered in Minnesota, United States. The company specialises in several domains including healthcare including medical devices and supplies, health information systems, oral care, personal protective equipment (PPE), drug delivery systems, healthcare manufacturing and safety solutions, and healthcare adhesives. In March 2024, 3M announced the approval of its planned spin-off healthcare business Solventum Corporation.
Smith & Nephew plc
Founded in 1856, the company is headquartered in Hertfordshire, England. It is a medical equipment manufacturing company specialising in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction, sports medicine, robotics, ENT, trauma, hip replacement, knee replacement, extremities, negative pressure wound therapy, ligament repair, and exudate management.
Coloplast A/S
Founded in 1957, Coloplast is headquartered in Humlebæk, Denmark. It develops products and services to make life easier for people with personal and private medical conditions commonly associated with trauma and taboos. Coloplast A/S works in ostomy care, continence care, wound and skin care, interventional urology, voice and respiratory care. In January 2024, the company launched Biatain® Silicone Fit, an innovation in advanced wound care under the foam dressing segment addressing the needs of both the advanced and traditional wound management market.
Mölnlycke Health Care AB
Established in 1849, the company is headquartered in Gothenburg, Sweden. It is a human centric MedTech company specialising in innovative healthcare solutions for wound care and surgical procedures. Mölnlycke operates in O.R. efficiency, antiseptics, surgical gloves, surgical drapes, surgical staff clothing, custom procedure trays, dressings with safetac technology, pressure ulcer prevention, wound treatment, medical solutions, wound management, surgical solutions, and wound care.
ConvaTec Group plc.
Founded in 1978, the company is headquartered in London, England. It is a medical equipment manufacturing company specialising in wound therapeutics, ostomy care, continence and critical care, infusion devices, medical devices, healthcare, hospitals, engineering, commercial, and research and development. In May 2024, Convatec, a leading global medical products and technologies company announced clinical study results from a recent multinational randomised controlled trial (RCT). The results highlighted the notable advancements in the healing of venous leg ulcers with AQUACEL® Ag+ Extra™ compared to traditional dressing.
Other players in the market include Integra LifeSciences Holdings Corporation, Medtronic PLC, Johnson and Johnson Services, Inc., B. Braun Melsungen AG, Paul Hartmann AG, and Cardinal Health.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Wound Type |
|
Breakup by Mode of Purchase |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124